Press Releases
Secrets to Reducing the Risk of Pressure Ulcer Litigation Revealed in Exclusive Webcast
MarketWire | 3 hours 6 minutes ago
MUNDELEIN, IL -- (Marketwire) -- 03/19/10 -- The outcome of a medical litigation is highly dependent on the words used in a care setting, arguably as important as the care delivered itself. In an exclusive webcast event presented by Medline Industries, Inc., legal and clinical experts reveal the secrets to how healthcare facilities can reduce their risk of pressure ulcer litigation, including how the utilization of the nursing process and proper documentation are vital components in maintai...... (more)
CryoLife Comments on Status of Medafor Distribution Agreement
PRNewswire | 11 hours 36 minutes ago
ATLANTA, March 19 /PRNewswire-FirstCall/ --- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, today responded to Medafor's allegation that it has repudiated the Exclusive Distribution Agreement ("Agreement") between the two companies.... (more)
Medafor Informs CryoLife that CryoLife Has Repudiated the Exclusive Distribution Agreement
Business Wire | 19 hours 6 minutes ago
Medafor Inc. said today that it sent a letter to CryoLife, Inc. (NYSE: CRY), informing the Company that by CryoLife’s failure to provide adequate assurance that it would properly perform its obligations under the two companies’ exclusive distribution agreement (“EDA”), CryoLife has effectively repudiated the contract between the two companies.... (more)
Haemonetics Announces Agreement to License Alba Blood Typing Reagents
PRNewswire | 21 hours 6 minutes ago
BRAINTREE, Mass., March 18 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE), a global blood management solutions company, today announced that it has entered into a reagent development and supply agreement with Quotient Biodiagnostics Group and its wholly owned subsidiary Alba Bioscience Limited. This arrangement provides Haemonetics with exclusive access to Alba's comprehensive catalogue of approved reagents for use in connection with the commercialization of its Arryx laser bas...... (more)
CryoLife Sends Letter to Medafor, Inc. Board of Directors
PRNewswire | 21 hours 6 minutes ago
ATLANTA, March 18 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has sent the following letter to Medafor's Board of Directors:... (more)
Emisphere Technologies and Alchemia to Research an Oral Formulation of Fondaparinux with Eligen Technology
Business Wire | 1 day 5 hours 6 minutes ago
Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) today announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug fondaparinux with Emisphere’s Eligen® Technology.... (more)
First Publication of Data from Pivotal Clinical Trial for Medtronic Deep Brain Stimulation Therapy for Epilepsy Published Today in Epilepsia
Business Wire | 1 day 5 hours 36 minutes ago
Medtronic, Inc. (NYSE:MDT) today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation (DBS) Therapy for epilepsy, known as SANTE® (Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy), was published online today in the medical journal, Epilepsia. The SANTE study, sponsored by Medtronic, is the largest and most rigorous clinical study of DBS therapy for epilepsy in adults with medically refractory epilepsy with parti...... (more)
OSI Systems Announces Appointment of New Board Member
Business Wire | 1 day 5 hours 36 minutes ago
OSI Systems, Inc. (NASDAQ:OSIS), a vertically-integrated provider of specialized electronics and services, today announced that following its recent Annual Shareholders Meeting, Dr. David T. Feinberg, Chief Executive Officer and Associate Vice Chancellor of the UCLA Hospital System, has been elected to the Company’s Board of Directors. The appointment follows the retirement of Dr. Chand R. Visanathan who had served as a Director of the Company since 2001.... (more)
BIOLASE Reports Fourth Quarter, Year-End Results
MarketWire | 1 day 7 hours 36 minutes ago
IRVINE, CA -- (Marketwire) -- 03/18/10 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today reported operating results for the 2009 fourth quarter and fiscal year ended December 31, 2009. ... (more)
Bioject Reports December 31, 2009 Results
Business Wire | 1 day 21 hours 6 minutes ago
Bioject Medical Technologies Inc. (OTCBB:BJCT), an innovative developer and manufacturer of needle-free injection therapy systems, today reported financial results for the year and quarter ended December 31, 2009.... (more)
Synergetics Announces Second Quarter Results
Business Wire | 1 day 21 hours 36 minutes ago
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative microsurgical instruments for ophthalmic and neurosurgical applications, today announced its results for the second quarter ended January 31, 2010. The Company reported second quarter 2010 sales of $13.0 million and net income of $877,000.... (more)
DURECT to Present at the Barclays Capital Global Healthcare Conference
PRNewswire | 1 day 21 hours 36 minutes ago
CUPERTINO, Calif., March 17 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that Matt Hogan, Chief Financial Officer, will be presenting at the Barclays Capital Global Healthcare Conference on Wednesday, March 24 at 8:30 am Eastern Time. The conference is being held at the Loews Miami Hotel, Florida.... (more)
EnteroMedics Extends Neuroblocking Technology Research and Development Collaboration
MarketWire | 1 day 21 hours 36 minutes ago
ST. PAUL, MN -- (Marketwire) -- 03/17/10 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that it has extended its 2005 collaboration agreement with the Mayo Clinic for an additional two years. The collaboration will continue to focus on the research and development of vagal-blocking technology for the treatment of obesity and other gastrointestinal disorders. EnteroMed...... (more)
Hill-Rom to Present at the Sidoti & Company Emerging Growth Conference
PRNewswire | 1 day 21 hours 36 minutes ago
BATESVILLE, Ind., March 17 /PRNewswire-FirstCall/ -- Hill-Rom (NYSE: HRC) announced today that Gregory N. Miller, senior vice president and chief financial officer, is scheduled to present at the Sidoti & Company Fourteenth Annual New York Emerging Growth Institutional Investor Conference on Tuesday, March 23, 2010. The event will not be webcast. Presentation slides will be available March 23 on the Hill-Rom website, http://ir.hill-rom.com/events.cfm, in the Investor Relations Events section.... (more)
Zimmer Holdings to Present at Barclays Capital 2010 Global Healthcare Conference
PRNewswire | 2 days 3 hours 36 minutes ago
WARSAW, Ind., March 17 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today it will be participating in the Barclays Capital 2010 Global Healthcare Conference in Miami, Fla., on March 23, 2010, at 8:30 a.m. Eastern Time. ... (more)
32 Press Releases | 
RSS Feed
Sign up for AdvaMed SmartBrief
Latest Blog Postsview more
Graphene used to make a hydrogen molecule parking garage
Science Blog
Nitrogen cruise ends, mission to explore undersea volcanism begins
Science Blog
Failed college dreams don't spell depression, study finds
Science Blog
Is Earth past the tipping point?
Science Blog
Companies in the news
- Acura Pharmaceuticals, Inc.
- Alkermes Inc
- Angiotech Pharmaceuticals, Inc.
- Boston Scientific Corporation
- Bovie Medical Corp.
- Elron
- Fresenius Kabi
- Fujifilm Medical Systems USA
- GE Healthcare
- Illumina Inc
- Kinetic Concepts Inc
- Medtronic Inc
- Ophthalmic Imaging Systems Inc.
- Sequenom Inc.
- Varian Medical Systems